tegafur has been researched along with Bladder Cancer in 68 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Forty patients with bladder cancer who underwent radiotherapy with angiotensin II, a hypertensor, and two cycles of arterial infusion of anticancer chemotherapies, including cisplatin 100 mg/body, were randomly assigned to a granisetron group and a non-granisetron group for comparative study of its prophylactic effect on nausea, vomiting and anorexia." | 9.08 | [The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer]. ( Hayashida, S; Hirasawa, T; Mitsui, H; Nasu, T; Shinohara, Y; Uchiyama, K, 1995) |
| "To evaluate the effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU), a derivative of 5-fluorouracil (5-FU), in preventing postoperative recurrence of bladder cancer, a randomized controlled study with 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) as the reference standard was performed." | 9.05 | [A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer]. ( Hisazumi, H; Kanda, S; Katsumi, T; Kawaguchi, K; Mikawa, I; Misaki, T; Miyagi, T; Nakamura, T; Orito, M; Sakai, A, 1985) |
| "The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma." | 7.67 | [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma]. ( Fujioka, Y; Hirasawa, S; Ishii, Y; Ito, H; Lin, TT; Nakagami, Y; Ogawa, H; Tanaka, K; Tannawa, K; Yamada, N, 1987) |
| "UFT, a compound containing uracil and tegafur (a prodrug of 5-fluorouracil) in a 4:1 molar ratio, has been used in Japan for the treatment of and as adjuvant chemotherapy for bladder cancer." | 6.19 | UFT in bladder cancer. ( Hosaka, M; Kubota, Y; Noguchi, S, 1999) |
| "Tegafur and Picibanil were added to the perfusate at the time of thermotherapy." | 5.27 | [Thermotherapy for cancer of the urinary bladder in combination with tegafur and picibanil--with special reference to the serum bladder and bladder cancer tissue concentrations of tegafur in a perfusion fluid]. ( Honda, M; Kanbe, K; Kaneko, K; Maeda, S; Murahashi, I; Takahashi, E, 1984) |
| "Forty patients with bladder cancer who underwent radiotherapy with angiotensin II, a hypertensor, and two cycles of arterial infusion of anticancer chemotherapies, including cisplatin 100 mg/body, were randomly assigned to a granisetron group and a non-granisetron group for comparative study of its prophylactic effect on nausea, vomiting and anorexia." | 5.08 | [The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer]. ( Hayashida, S; Hirasawa, T; Mitsui, H; Nasu, T; Shinohara, Y; Uchiyama, K, 1995) |
| "We evaluated 63 patients with superficial bladder cancer (pTa, pTl) who were treated with instillation of bleomycin +/- bacillus Calmette-Guerin (BCG) and administration of uraciltfutraful (UFT) for prophylaxis of tumor recurrence after transurethral resection (TUR)." | 5.07 | [Prophylactic combination therapy after TUR of superficial bladder cancer]. ( Adachi, K; Ao, T; Endo, T; Kawakami, T; Koshiba, K; Mashimo, S; Uchida, T; Yokoyama, E, 1993) |
| "To evaluate the effect of UFT, a mixture of ftorafur and uracil in a ratio of 1:4, in preventing postoperative recurrence of bladder cancer, we performed a randomized controlled study with a non-medication group as control." | 5.06 | [Prophylactic effect of UFT on the recurrence of bladder cancer]. ( Ejiri, S; Hisazumi, H; Kanda, S; Katsumi, T; Kitagawa, K; Mikawa, I; Miyagi, T; Naito, K; Nakamura, T; Saka, A, 1990) |
| "To evaluate the effect of 1-hexylcarbamoyl-5-fluorouracil (HCFU), a derivative of 5-fluorouracil (5-FU), in preventing postoperative recurrence of bladder cancer, a randomized controlled study with 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) as the reference standard was performed." | 5.05 | [A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer]. ( Hisazumi, H; Kanda, S; Katsumi, T; Kawaguchi, K; Mikawa, I; Misaki, T; Miyagi, T; Nakamura, T; Orito, M; Sakai, A, 1985) |
| " UFT (a compound of tegafur and uracil) is said to be effective for bladder cancer." | 4.80 | [Progress in oral anti-cancer drug therapy for urological cancer]. ( Akaza, H; Tsukamoto, S, 1999) |
| " 5-Fluorouracil (5-FU) was effective against only one bladder cancer xenograft among 6 cancer xenografts tested." | 3.68 | [Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice]. ( Adachi, S; Akaza, H; Ishitsuka, H; Kanazawa, K; Miwa, M; Nitta, K; Sekiguchi, F; Tokita, H, 1991) |
| "The safety of prolonged administration of UFT in which tegafur and uracil were mixed in a ratio of 1:4 in molar fraction was studied in 44 cases of bladder cancer and 10 cases of renal cell carcinoma." | 3.67 | [Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma]. ( Fujioka, Y; Hirasawa, S; Ishii, Y; Ito, H; Lin, TT; Nakagami, Y; Ogawa, H; Tanaka, K; Tannawa, K; Yamada, N, 1987) |
| "UFT (a mixture of futraful and uracil) was administered orally to 15 cases of recurrent and superficial bladder cancer principally for more than 4 weeks at the doses of 300 or 600 mg per day." | 3.66 | [Clinical effect of UFT on bladder cancer]. ( Asahi, T; Kaneshige, T; Kumon, H; Matsumura, Y; Ohmori, H; Ozaki, Y; Tsushima, T; Yoshimoto, J, 1982) |
| "In the study of prostate cancer, neither a significant difference of non-recurrent rate nor of survival rate was seen between the two groups." | 2.69 | [Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group]. ( Akaza, H; Hattori, K; Ishikawa, S; Kawai, K; Kikuchi, K; Kobayashi, T; Koiso, K; Kondo, F; Manabe, F; Matsuki, K; Miyanaga, N; Noguchi, R; Shimazui, T; Suzuki, R; Takeshima, H; Tsuchiya, A; Uchida, K, 1998) |
| "To prevent postoperative recurrence a randomized prospective trial was performed on 45 patients with bladder cancers by dividing them into 2 groups given either UFT therapy alone or UFT therapy in combination with Bestatin." | 2.68 | Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin. ( Koshida, K; Kunimi, K; Uchibayashi, T; Yamamoto, H, 1995) |
| "A 67-year-old man with bladder cancer who was treated with transurethral resection of bladder tumour(TUR-Bt)and chemotherapy at the age of 59 years was diagnosed as having urothelial cancer by biopsy 8 years later." | 2.49 | [A case of quadruple cancer of the liver, stomach, bladder, and ureter]. ( Fukuoka, M; Nishizawa, Y; Omura, N; Tachibana, S; Tatara, T; Tatsumi, Y; Yoshida, T; Yoshimura, H, 2013) |
| "In urinary bladder cancer, the combination chemotherapy with 5-FU and low-dose CDDP has been used as a radiosensitizer." | 2.40 | [Combination chemotherapy with 5-FU and low-dose CDDP for urogenital tumors]. ( Fujinami, K; Kubota, Y, 1999) |
| "Computed tomographic scan revealed the bladder tumors and swelling of the internal iliac lymph nodes." | 2.40 | [A case of urothelial carcinoma associated with penile metastasis]. ( Horinaga, M; Ikeuchi, K; Kosugi, M, 1999) |
| "Herein, we report a bladder cancer case with multiple metastases which were controlled by low-dose UFT." | 1.37 | [A case of marked efficacy of low-dose UFT against metastatic bladder cancer]. ( Arai, Y; Ito, A; Kuwahara, M; Nakano, O; Satoh, M, 2011) |
| "In the bladder cancer patients, the mean F-RNAs in the bladder tumor and normal tissue were 0." | 1.35 | 5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil. ( Fujimoto, K; Hirao, Y; Okajima, E; Ozono, S; Tsujimoto, S, 2008) |
| "She had a history of superficial bladder tumors which were treated with transurethral resection (TURBT)." | 1.34 | [Superficial bladder cancer with lung metastasis without local invasion: a case report]. ( Ao, T; Baba, S; Hirayama, T; Irie, A; Iwabuchi, K; Iwamura, M; Kudoh, O; Matsumoto, K; Uchida, T, 2007) |
| "The diagnosis was bladder cancer (TCC, G3, T4N3M1) from detailed examination." | 1.30 | [A case of untreatable progressive bladder carcinoma effectively treated by single administration of tegafur and uracil]. ( Goto, R; Ikeuchi, T; Kai, Y; Ota, M; Yoshikawa, H, 1998) |
| "(METHOD)." | 1.29 | [The long-term effect and outcome of preoperative chemotherapy combined with radiation therapy for bladder cancer]. ( Hayashida, S; Kamata, S; Mitsui, H; Nakane, H; Nasu, T, 1996) |
| " Since she complained of olfactory anesthesia at 2 months of treatment, the dosage of UFT was reduced to 2 capsules daily and the drug was withdrawn after another 2 months of treatment." | 1.28 | [Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report]. ( Fukuoka, H; Nomura, S; Ogawa, T; Sakanishi, S; Takeda, M, 1991) |
| "Tegafur and Picibanil were added to the perfusate at the time of thermotherapy." | 1.27 | [Thermotherapy for cancer of the urinary bladder in combination with tegafur and picibanil--with special reference to the serum bladder and bladder cancer tissue concentrations of tegafur in a perfusion fluid]. ( Honda, M; Kanbe, K; Kaneko, K; Maeda, S; Murahashi, I; Takahashi, E, 1984) |
| "The 5-FU concentration of prostatic cancer was almost equal to that of normal prostatic tissue." | 1.27 | [Study on the concentration of FT-207 and 5-FU in serum and tissues of bladder tumor and prostatic carcinoma]. ( Kobayashi, H; Obata, K; Sahashi, M, 1986) |
| "Thermotherapy combined with tegafur (FT-207) and Picibanil was performed in 13 patients with cancer of the urinary bladder." | 1.27 | [Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma]. ( Arai, T; Honda, M; Kanbe, K; Kaneko, K; Maeda, S; Mukae, K; Murahashi, I; Sakuma, H; Tabata, Y; Takasaki, E, 1985) |
| "In Groups 1 to 5, urinary bladder tumors developed in 20 of 20, 13 of 20, 6 of 20, 14 of 20 and 6 of 20, respectively." | 1.27 | [Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine]. ( Babaya, K; Hirao, Y; Matsuki, H; Moriya, A; Nakatsuji, F; Okajima, E; Samma, S; Tabata, S; Watanabe, S; Yoshie, T, 1985) |
| "Urinary bladder tumors were induced in 18 of 20 rats (90." | 1.26 | [Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer]. ( Babaya, K; Hiramatsu, T; Hirao, Y; Ijuin, M; Kihoin, K; Maruyama, Y; Ohara, S; Okajima, E; Tanaka, M, 1982) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 25 (36.76) | 18.7374 |
| 1990's | 26 (38.24) | 18.2507 |
| 2000's | 9 (13.24) | 29.6817 |
| 2010's | 8 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ide, H | 1 |
| Kikuchi, E | 1 |
| Hasegawa, M | 1 |
| Hattori, S | 1 |
| Yasumizu, Y | 1 |
| Miyajima, A | 1 |
| Oya, M | 1 |
| Omura, N | 1 |
| Fukuoka, M | 1 |
| Tachibana, S | 1 |
| Yoshimura, H | 1 |
| Tatsumi, Y | 1 |
| Yoshida, T | 1 |
| Nishizawa, Y | 1 |
| Tatara, T | 1 |
| Yoshida, Y | 1 |
| Yamanaka, K | 1 |
| Ueda, N | 1 |
| Hirai, T | 1 |
| Kishikawa, H | 1 |
| Nishimura, K | 1 |
| Ichikawa, Y | 1 |
| Nomi, H | 1 |
| Takahara, K | 1 |
| Minami, K | 1 |
| Maenosono, R | 1 |
| Matsunaga, T | 1 |
| Yoshikawa, Y | 1 |
| Tsujino, T | 1 |
| Hirano, H | 1 |
| Inamoto, T | 1 |
| Yamamoto, I | 1 |
| Tsuji, M | 1 |
| Kiyama, S | 1 |
| Azuma, H | 1 |
| Ishiura, Y | 1 |
| Yamamoto, H | 2 |
| Terasaki, Y | 1 |
| Ishida, Y | 1 |
| Yokawa, S | 1 |
| Fukushima, W | 1 |
| Hirosawa, H | 1 |
| Izumi, R | 1 |
| Kodama, K | 1 |
| Motoi, I | 1 |
| Tanikawa, F | 1 |
| Ichihashi, K | 1 |
| Maruyama, K | 1 |
| Miyazu, M | 1 |
| Yoneda, K | 1 |
| Saito, K | 2 |
| Kasahara, K | 2 |
| Fujimura, M | 2 |
| Takagi, T | 1 |
| Nakase, Y | 1 |
| Fukumoto, K | 1 |
| Miyagaki, T | 1 |
| Onishi, A | 1 |
| Koyama, M | 1 |
| Imada, N | 1 |
| Kobayashi, Y | 1 |
| Kanemitsu, D | 1 |
| Kassai, K | 1 |
| Sakamoto, K | 1 |
| Takenaka, S | 1 |
| Itani, K | 1 |
| Fukumoto, I | 1 |
| Sekita, N | 1 |
| Arai, H | 1 |
| Shibata, N | 1 |
| Nishikawa, R | 1 |
| Sugano, I | 1 |
| Mikami, K | 1 |
| Satoh, M | 1 |
| Nakano, O | 1 |
| Kuwahara, M | 1 |
| Ito, A | 1 |
| Arai, Y | 2 |
| Matsushita, S | 1 |
| Yonekura, K | 1 |
| Mera, K | 1 |
| Kawai, K | 2 |
| Kanekura, T | 1 |
| Server Pastor, G | 1 |
| Rigabert Montiel, M | 1 |
| Bañón Pérez, V | 1 |
| Valdelvira Nadal, P | 1 |
| Cao Avellaneda, E | 1 |
| García Hernández, JA | 1 |
| Pérez Albacete, M | 1 |
| Kojima, Y | 1 |
| Yamada, Y | 2 |
| Kamisawa, H | 1 |
| Sasaki, S | 1 |
| Hayashi, Y | 1 |
| Kohri, K | 1 |
| Zang, ZL | 1 |
| Liu, SQ | 1 |
| Chen, X | 1 |
| Li, YJ | 1 |
| Zhou, B | 1 |
| Xu, XH | 1 |
| Hirayama, T | 1 |
| Matsumoto, K | 1 |
| Irie, A | 1 |
| Iwamura, M | 1 |
| Kudoh, O | 1 |
| Iwabuchi, K | 1 |
| Ao, T | 2 |
| Uchida, T | 2 |
| Baba, S | 1 |
| Tsujimoto, S | 1 |
| Fujimoto, K | 1 |
| Okajima, E | 6 |
| Ozono, S | 3 |
| Hirao, Y | 5 |
| Edsmyr, F | 1 |
| Andersson, L | 1 |
| Esposti, PL | 1 |
| Fujihiro, S | 1 |
| Takeuchi, T | 1 |
| Fujimoto, Y | 1 |
| Okano, M | 1 |
| Horie, M | 1 |
| Kanematsu, M | 1 |
| Kuriyama, M | 1 |
| Ban, Y | 1 |
| Nishiura, T | 1 |
| Ohmori, H | 2 |
| Mishina, T | 3 |
| Kobayashi, T | 4 |
| Maegawa, M | 3 |
| Nakao, M | 3 |
| Nakagawa, S | 3 |
| Uyama, T | 1 |
| Aga, Y | 1 |
| Yonezawa, M | 1 |
| Yamamoto, A | 1 |
| Sumiyoshi, Y | 1 |
| Fujita, J | 1 |
| Watanabe, H | 2 |
| Masuda, F | 2 |
| Tashiro, K | 1 |
| Machida, T | 1 |
| Shida, K | 1 |
| Yamanaka, H | 1 |
| Ito, Y | 1 |
| Shimazaki, J | 1 |
| Isaka, S | 1 |
| Yokokawa, M | 1 |
| Fukui, I | 1 |
| Kawai, H | 1 |
| Akimoto, M | 1 |
| Yoshida, K | 3 |
| Numasawa, K | 1 |
| Kakizaki, H | 1 |
| Takamizawa, A | 1 |
| Kubota, Y | 4 |
| Suzuki, K | 1 |
| Murahashi, I | 2 |
| Kanbe, K | 2 |
| Kaneko, K | 2 |
| Honda, M | 2 |
| Maeda, S | 2 |
| Takahashi, E | 1 |
| Fujiwara, T | 1 |
| Hiramatsu, T | 3 |
| Kihoin, K | 1 |
| Ijuin, M | 1 |
| Ohara, S | 2 |
| Babaya, K | 3 |
| Tanaka, M | 1 |
| Maruyama, Y | 2 |
| Asahi, T | 1 |
| Matsumura, Y | 1 |
| Ozaki, Y | 1 |
| Yoshimoto, J | 1 |
| Kaneshige, T | 1 |
| Kumon, H | 1 |
| Tsushima, T | 1 |
| Yokoyama, E | 1 |
| Kawakami, T | 1 |
| Adachi, K | 1 |
| Mashimo, S | 1 |
| Endo, T | 1 |
| Koshiba, K | 1 |
| Hayashida, S | 2 |
| Hirasawa, T | 1 |
| Uchiyama, K | 1 |
| Mitsui, H | 2 |
| Nasu, T | 2 |
| Shinohara, Y | 1 |
| Washida, H | 1 |
| Tozawa, K | 1 |
| Honma, H | 1 |
| Kang, K | 1 |
| Nakamoto, T | 2 |
| Igawa, M | 2 |
| Usui, T | 3 |
| Takeyama, M | 1 |
| Honjoh, M | 1 |
| Ohnishi, N | 1 |
| Ishikawa, Y | 1 |
| Sakaguchi, H | 1 |
| Hanai, J | 1 |
| Hosaka, M | 2 |
| Fukushima, S | 1 |
| Kondo, I | 1 |
| Uchibayashi, T | 1 |
| Kunimi, K | 1 |
| Koshida, K | 1 |
| Nakane, H | 1 |
| Kamata, S | 1 |
| Uchida, K | 2 |
| Takeshima, H | 1 |
| Kikuchi, K | 1 |
| Shimazui, T | 1 |
| Miyanaga, N | 1 |
| Akaza, H | 3 |
| Tsuchiya, A | 1 |
| Noguchi, R | 1 |
| Hattori, K | 1 |
| Manabe, F | 1 |
| Matsuki, K | 1 |
| Suzuki, R | 1 |
| Ishikawa, S | 1 |
| Kondo, F | 1 |
| Koiso, K | 3 |
| Goto, R | 1 |
| Yoshikawa, H | 1 |
| Ota, M | 1 |
| Ikeuchi, T | 1 |
| Kai, Y | 1 |
| Tsukamoto, S | 1 |
| Noguchi, S | 1 |
| Fujinami, K | 1 |
| Horinaga, M | 1 |
| Kosugi, M | 1 |
| Ikeuchi, K | 1 |
| Inoue, K | 1 |
| Shuin, T | 1 |
| Yano, A | 1 |
| Hashimoto, K | 1 |
| Okuchi, T | 1 |
| Mizoguchi, H | 1 |
| Mutaguchi, K | 1 |
| Touyama, H | 1 |
| Hokama, S | 1 |
| Hatano, T | 2 |
| Ogawa, Y | 1 |
| Yoshida, O | 1 |
| Kakehi, Y | 1 |
| Nishio, Y | 1 |
| Tomoyoshi, T | 2 |
| Konami, T | 2 |
| Takenaka, I | 1 |
| Fujita, K | 1 |
| Hayashi, J | 1 |
| Hidaka, N | 1 |
| Sanda, M | 1 |
| Ohashi, N | 1 |
| Yajima, Y | 1 |
| Furukawa, Y | 1 |
| Kato, M | 1 |
| Samma, S | 2 |
| Sasaki, K | 1 |
| Watanabe, S | 3 |
| Mori, Y | 1 |
| Torii, S | 1 |
| Kawashima, Y | 1 |
| Kobari, T | 1 |
| Hosobe, T | 1 |
| Nishijima, Y | 2 |
| Nemoto, R | 2 |
| Kanimoto, Y | 1 |
| Suzuki, Y | 1 |
| Miwa, Y | 1 |
| Akino, H | 1 |
| Isomatu, Y | 1 |
| Okada, K | 1 |
| Miwa, M | 1 |
| Sekiguchi, F | 1 |
| Tokita, H | 1 |
| Nitta, K | 1 |
| Adachi, S | 1 |
| Kanazawa, K | 1 |
| Ishitsuka, H | 1 |
| Fukuoka, H | 1 |
| Takeda, M | 1 |
| Nomura, S | 2 |
| Ogawa, T | 1 |
| Sakanishi, S | 1 |
| Hinotsu, S | 1 |
| Unda Urzaiz, M | 1 |
| Zubiaur Líbano, C | 1 |
| Pérez Fernández, A | 1 |
| Iriarte Soldevilla, JI | 1 |
| Flores Corral, N | 1 |
| Naito, K | 1 |
| Hisazumi, H | 2 |
| Saka, A | 1 |
| Nakamura, T | 2 |
| Kanda, S | 2 |
| Mikawa, I | 2 |
| Ejiri, S | 1 |
| Miyagi, T | 2 |
| Katsumi, T | 2 |
| Kitagawa, K | 1 |
| Oda, H | 1 |
| Seki, N | 1 |
| Nabeshima, S | 1 |
| Oda, T | 1 |
| Nishio, S | 1 |
| Yokoyama, M | 1 |
| Iwata, H | 1 |
| Takeuchi, M | 1 |
| Matsumoto, A | 1 |
| Terado, T | 1 |
| Nakano, E | 1 |
| Iwasaki, A | 1 |
| Seguchi, T | 1 |
| Sugao, H | 1 |
| Yoshioka, T | 1 |
| Tada, Y | 1 |
| Matsuda, M | 1 |
| Sonoda, T | 1 |
| Takahashi, T | 1 |
| Gelabert Mas, A | 1 |
| Arango Toro, O | 1 |
| Rosales Bordes, A | 1 |
| Coronado García, J | 1 |
| Fernández Zuazu, J | 1 |
| Nakame, Y | 1 |
| Horiuchi, S | 1 |
| Kaneoya, F | 1 |
| Kuroda, T | 1 |
| Tanoiri, A | 1 |
| Koizumi, M | 1 |
| Takahashi, M | 1 |
| Negishi, T | 1 |
| Saitoh, H | 1 |
| Kobayashi, H | 1 |
| Sahashi, M | 1 |
| Obata, K | 1 |
| Takayama, H | 1 |
| Konishi, T | 1 |
| Pak, K | 1 |
| Yamada, K | 1 |
| Aoyama, H | 1 |
| Hashimoto, M | 1 |
| Nakagami, Y | 1 |
| Lin, TT | 1 |
| Ito, H | 1 |
| Hirasawa, S | 1 |
| Tannawa, K | 1 |
| Fujioka, Y | 1 |
| Ogawa, H | 1 |
| Tanaka, K | 1 |
| Yamada, N | 1 |
| Ishii, Y | 1 |
| Sato, K | 1 |
| Miyazato, T | 1 |
| Saito, S | 1 |
| Kashiwabara, N | 1 |
| Igarashi, M | 1 |
| Koyama, Y | 1 |
| Hayakawa, M | 1 |
| Osawa, A | 1 |
| Mukae, K | 1 |
| Tabata, Y | 1 |
| Sakuma, H | 1 |
| Arai, T | 1 |
| Takasaki, E | 1 |
| Tabata, S | 1 |
| Nakatsuji, F | 1 |
| Yoshie, T | 1 |
| Moriya, A | 1 |
| Matsuki, H | 1 |
| Misaki, T | 1 |
| Sakai, A | 1 |
| Orito, M | 1 |
| Kawaguchi, K | 1 |
5 reviews available for tegafur and Bladder Cancer
| Article | Year |
|---|---|
[A case of quadruple cancer of the liver, stomach, bladder, and ureter].
Topics: Aged; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Drug Combinations; Humans; Liver Neop | 2013 |
[Progress in oral anti-cancer drug therapy for urological cancer].
Topics: Administration, Oral; Androgen Antagonists; Antineoplastic Agents, Hormonal; Drug Administration Sch | 1999 |
UFT in bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Humans; Tegafur; | 1999 |
[Combination chemotherapy with 5-FU and low-dose CDDP for urogenital tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Cisplatin; Combined Modality | 1999 |
[A case of urothelial carcinoma associated with penile metastasis].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Humans; Lymphati | 1999 |
15 trials available for tegafur and Bladder Cancer
| Article | Year |
|---|---|
[Oral tegafur plus mitomycin versus intravesical mitomycin alone in the prevention of recurrence in stage Ta bladder tumors].
Topics: Administration, Intravesical; Administration, Oral; Antibiotics, Antineoplastic; Antineoplastic Agen | 2003 |
[Prophylactic combination therapy after TUR of superficial bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic C | 1993 |
[The preventive effect of granisetron on digestive tract symptoms induced by arterial infusion of anticancer and hypertensive agents in combination with radiotherapy--a study of forty patients with bladder cancer].
Topics: Aged; Angiotensin II; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Blood Pressure; Chil | 1995 |
Prophylactic oral UFT therapy for superficial bladder cancer.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 1993 |
Adjuvant therapy with 5-fluoro-1-(2-tetrahydrofuryl)-2,4 (1H,3H)-pyrimidinedione (UFT) and Bestatin in patients with transitional cell carcinoma of the bladder--comparison between UFT therapy alone and UFT therapy in combination with Bestatin.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antibiotics, Antineoplastic; Antineoplastic Co | 1995 |
[Effect of UFT on treatment of urological cancer--effect of UFT on treatment of invasive bladder cancer and advanced prostate cancer. Ibaraki Urological Cancer Chemotherapy Study Group].
Topics: Administration, Oral; Aged; Aged, 80 and over; Androgen Antagonists; Antineoplastic Agents; Antineop | 1998 |
UFT in bladder cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Clinical Trials, Phase II as Topic; Humans; Tegafur; | 1999 |
[Prophylactic effect of UFT in combination with intravesical chemotherapy on the recurrence of superficial bladder tumor].
Topics: Administration, Intravesical; Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic C | 1992 |
A prospective randomized study of prophylaxis of tumor recurrence following transurethral resection of superficial bladder cancer--intravesical thio-TEPA versus oral UFT.
Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Proto | 1992 |
[A comparative clinical trial of UFT treatment and intravesical adriamycin instillation to prevent recurrence of superficial bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; | 1992 |
[Adriamycin versus ftorafur in the prevention of recurrence of superficial carcinoma of the bladder].
Topics: Carcinoma; Doxorubicin; Drug Evaluation; Humans; Neoplasm Recurrence, Local; Neoplasm Staging; Prosp | 1990 |
[Prophylactic effect of UFT on the recurrence of bladder cancer].
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols | 1990 |
[A comparative clinical trial of UFT medication and intravesical BCG in the recurrence of superficial bladder cancer. Study Group of UFT and BCG adjuvant therapy for bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Aged; Aged, 80 and over; Antineoplastic Combined | 1990 |
Prophylactic treatment for superficial bladder cancer following transurethral resection.
Topics: Administration, Intravesical; Aged; Antineoplastic Agents; Carcinoma, Transitional Cell; Combined Mo | 1987 |
[A randomized controlled study to compare 1-hexylcarbamoyl-5-fluorouracil (HCFU) and 1-(2-tetrahydrofuryl)-5-fluorouracil (Tegafur) for the prevention of post-operative recurrence of bladder cancer].
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Clinical Trials as Topic; Drug Administrat | 1985 |
49 other studies available for tegafur and Bladder Cancer
| Article | Year |
|---|---|
Therapeutic enhancement of S-1 with CPT-11 through down-regulation of thymidylate synthase in bladder cancer.
Topics: Animals; Camptothecin; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; D | 2013 |
[A case of urachal carcinoma with multiple lung metastases treated by TS-1/CDDP chemotherapy].
Topics: Adenocarcinoma; Aged; Antigens, Tumor-Associated, Carbohydrate; Antineoplastic Combined Chemotherapy | 2014 |
[A CASE OF ADVANCED BLADDER NEUROENDOCRINE CARCINOMA (SMALL CELL CARCINOMA) SIGNIFICANTLY IMPROVED BY LOW DOSE OF ORAL TEGAFUR-URACIL].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Small Cell; Chemothera | 2015 |
[A case of synchronous triple cancer involving lung, stomach and bladder, responding to combination chemotherapy of S-1 and cisplatin].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; Gastroscopy; Hum | 2008 |
[A case of metastatic bladder cancer occurring after surgery for differentiated gastric cancer controlled by combination therapy of paclitaxel/S-1].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Cell Differentiation; Drug Combinations; Human | 2010 |
[A case of urachal carcinoma treated with S-1/CDDP combination chemotherapy].
Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chem | 2010 |
[A case of marked efficacy of low-dose UFT against metastatic bladder cancer].
Topics: Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Combined Modality Therapy; Female | 2011 |
Successful treatment of metastatic extramammary Paget's disease with S-1 and docetaxel combination chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Docetaxel; Drug Combinations; | 2011 |
Complete response of a recurrent advanced urachal carcinoma treated by S-1/cisplatin combination chemotherapy.
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Drug Combinations; | 2006 |
[Synthesis and antitumor activity of selenophosphocholine analogues containing tegafur].
Topics: Antineoplastic Agents; Cell Line, Tumor; Humans; Magnetic Resonance Spectroscopy; Organoselenium Com | 2006 |
[Superficial bladder cancer with lung metastasis without local invasion: a case report].
Topics: Administration, Intravesical; Administration, Oral; Aged; Antineoplastic Agents; BCG Vaccine; Carcin | 2007 |
5-Fluorouracil incorporated into the tissue RNA of human and rat bladder carcinoma after administration of 1-(2-tetrahydrofuryl)-5-fluorouracil combined with uracil.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; | 2008 |
Chemotherapy in advanced urinary bladder cancer.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; | 1984 |
[Chemotherapy of urothelial cancer with vincristine, mitomycin C, bleomycin, tegafur and OK-432].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Combined Modality Therapy; Female; | 1984 |
[Intravesical chemotherapy for superficial bladder tumors].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carbazilquinone; Cytarabine; Doxorubicin; | 1984 |
Development and clinical application of an AFC regimen (adriamycin, futraful, cytosine arabinoside) for superficial bladder tumors.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Cytarabin | 1983 |
Prophylactic long-term treatment of bladder tumors with oral chemotherapy (tegafur).
Topics: Actuarial Analysis; Administration, Oral; Adult; Aged; Combined Modality Therapy; Female; Fluorourac | 1984 |
[Clinical application of tegafur suppositories for bladder tumor].
Topics: Adult; Aged; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Fluorouracil; Humans; Male; Mid | 1983 |
[Clinical effect of UFT on urogenital tumors].
Topics: Adenocarcinoma; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone an | 1984 |
[Phase II study of UFT for malignant tumors of urinary organs].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Drug Administration Schedule; Drug Comb | 1984 |
[A study of post-operative chemotherapy for renal pelvic and ureteral tumors].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromomycin A3; Cisplatin; Cytarabine; | 1984 |
[Thermotherapy for cancer of the urinary bladder in combination with tegafur and picibanil--with special reference to the serum bladder and bladder cancer tissue concentrations of tegafur in a perfusion fluid].
Topics: Aged; Biological Products; Combined Modality Therapy; Drug Therapy, Combination; Female; Fluorouraci | 1984 |
Immunochemotherapy for advanced bladder cancer using FT-207, adriamycin and OK-432.
Topics: Adjuvants, Immunologic; Aged; Doxorubicin; Drug Therapy, Combination; Female; Fluorouracil; Humans; | 1982 |
[Effect of FT-207 on bladder cancer in rats induced by BBN. II: The effect of oral administration of FT-207 during oncogenesis of bladder cancer].
Topics: Administration, Oral; Animals; Antineoplastic Agents; Body Weight; Butylhydroxybutylnitrosamine; Flu | 1982 |
[Clinical effect of UFT on bladder cancer].
Topics: Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Drug Combinations; Fema | 1982 |
[Intravesical bacillus Calmette-Guerin therapy for superficial bladder cancer].
Topics: Administration, Intravesical; Administration, Oral; Antineoplastic Combined Chemotherapy Protocols; | 1994 |
[Successful inhibition of bladder tumor recurrence by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional | 1994 |
[Relationship between tissue concentrations of 5-FU and degeneration of tissues after UFT administration in patients with bladder tumor].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Fluorouracil; Humans; Middl | 1993 |
[The long-term effect and outcome of preoperative chemotherapy combined with radiation therapy for bladder cancer].
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Combined | 1996 |
[A case of untreatable progressive bladder carcinoma effectively treated by single administration of tegafur and uracil].
Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Carcinoma, Transitional Cell; Drug Administration Sc | 1998 |
Advanced adenocarcinoma of the urinary bladder successfully treated by the combination of cisplatinum, mitomycin-C, etoposide and tegafur-uracil chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Etoposide; Female; Humans | 2001 |
[Dihydropyrimidine dehydrogenase activity in urothelial cancer--influence of UFT administration on DPD activity].
Topics: Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Dihydrouracil Dehydrogenase | 2001 |
[Primary signet ring cell carcinoma of the urinary bladder: a case report].
Topics: Aged; Antineoplastic Agents; Carcinoma, Signet Ring Cell; Drug Combinations; Humans; Male; Tegafur; | 2001 |
[A effective combination preoperative intraarterial infusion chemotherapy and irradiation for advanced sigmoid colon cancer with bladder invasion].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemotherapy, Adjuvant; Cisplatin; Combined Modality | 1992 |
[Effect of UFT on experimental spinal metastasis in the mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; FANFT; Female; Mice; Mice, Inbred C3H; Neop | 1992 |
[Thymidylate synthase inhibition and concentration of 5-fluorouracil after administration of UFT in human uroepithelial carcinomas].
Topics: Adenocarcinoma, Mucinous; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Proto | 1991 |
[Comparative studies on the antitumor activity of fluorinated pyrimidine derivatives against human bladder, cervical and ovarian cancer xenografts in nude mice].
Topics: Administration, Oral; Animals; Antineoplastic Combined Chemotherapy Protocols; Female; Floxuridine; | 1991 |
[Complete remission of lung metastases of bladder tumor treated by small dosage of UFT: a case report].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; Female; Humans; Lung N | 1991 |
[Effect of UFT with high dose leucovorin for transplantable bladder tumor (MBT-2) in mice].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Body Weight; Drug Synergism; Leucovorin; Mi | 1991 |
[Case report of a complete regression of para-aortic lymph node metastasis from bladder cancer by oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional | 1989 |
[A case report of retrovesical tumor effectively responsive to chemotherapy].
Topics: Adenocarcinoma; Adult; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Mal | 1989 |
[Oral cytostatic agents in the prevention of urothelial carcinoma. Our experience].
Topics: Administration, Oral; Adult; Aged; Carcinoma, Transitional Cell; Drug Eruptions; Foot Dermatoses; Ha | 1988 |
[Effect of combination chemotherapy of tegafur, adriamycin and cisplatin on patients with advanced relapsing prostatic carcinoma and advanced bladder tumor].
Topics: Adenocarcinoma; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Transitional Cell; | 1986 |
[Study on the concentration of FT-207 and 5-FU in serum and tissues of bladder tumor and prostatic carcinoma].
Topics: Adult; Aged; Fluorouracil; Humans; Male; Middle Aged; Prostate; Prostatic Neoplasms; Suppositories; | 1986 |
[Studies on 5-FU concentration in serum and bladder tumor tissue after oral administration of UFT].
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fluorouracil; Hu | 1986 |
[Clinical experience of tegafur-uracil (UFT) against bladder cancer and renal cell carcinoma].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Renal Cell; Carcinoma, Trans | 1987 |
[Clinical studies of the treatment of bladder tumor and its effects--experience in 86 cases].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Squamous Cell; Carcinoma, Tr | 1988 |
[Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma].
Topics: Adult; Aged; Biological Products; Carcinoma, Squamous Cell; Carcinoma, Transitional Cell; Female; Fl | 1985 |
[Effect of UFT on urinary bladder tumors in rats induced by N-butyl-N-(4-hydroxybutyl)nitrosamine].
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Butylhydroxybutylnitrosamine; Drug Administ | 1985 |